✦ LIBER ✦

Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer

✍ Scribed by Amit M. Algotar; M. Suzanne Stratton; Frederick. R. Ahmann; James Ranger-Moore; Raymond B. Nagle; Patricia A. Thompson; Elizabeth Slate; Chiu H. Hsu; Bruce L. Dalkin; Puneet Sindhwani; Michael A. Holmes; John A. Tuckey; David. L. Graham; Howard L. Parnes; Lawrence C. Clark; Steven P. Stratton

Book ID: 115561367
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 122 KB
Volume: 73
Category: Article
ISSN: 0270-4137
DOI: 10.1002/pros.22573

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase III clinical trial of exercise m

A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer

✍ Robert U Newton; Dennis R Taaffe; Nigel Spry; Robert A Gardiner; Gregory Levin; 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 299 KB

Sipuleucel-T immune parameters correlate

Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer

✍ Nadeem A. Sheikh, Daniel Petrylak, Philip W. Kantoff, Corazon dela Rosa, Frances 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 561 KB

A phase 3 randomized controlled trial of

A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer

✍ Michael A. Carducci; Fred Saad; Per-Anders Abrahamsson; David P. Dearnaley; Clau 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 2 views

## Abstract ## BACKGROUND. The objective of this study was to evaluate the efficacy and safety of atrasentan (Xinlay), a selective endothelin‐A receptor antagonist, in patients with metastatic hormone‐refractory prostate cancer (HRPC). ## METHODS. This multinational, double‐blind, placebo‐contro

Final results of the Canadian prospectiv

Final results of the Canadian prospective phase II trial of intermittent androgen suppression for men in biochemical recurrence after radiotherapy for locally advanced prostate cancer : Clinical parameters

✍ Nicholas Bruchovsky; Laurence Klotz; Juanita Crook; Shawn Malone; Charles Ludgat 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 2 views

The effect of clinical trial participati

The effect of clinical trial participation versus non-participation on overall survival in men receiving first-line docetaxel-containing chemotherapy for metastatic castration-resistant prostate cancer

✍ Jatinder Goyal; Philipp Nuhn; Peng Huang; Prachi Tyagi; Daniel Oh; Michael A. Ca 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

The absence of voiding symptoms in men w

The absence of voiding symptoms in men with a prostate-specific antigen (PSA) concentration of ≥3.0 ng/mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening Trial

✍ Maria Frånlund; Sigrid Carlsson; Johan Stranne; Gunnar Aus; Jonas Hugosson 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB